| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |